Latest Liquidity News

Revolver Resources has completed a key drilling program at its Dianne Copper Mine Project, affirming resource estimates and progressing towards a targeted production restart in late 2026. The company also secured significant funding to support upcoming development milestones.

Kalamazoo Resources Limited reported a cash position of A$1.375 million at the end of September 2025, highlighting ongoing negative cash flows but confidence in securing future funding to sustain operations.

Australian Pacific Coal Limited has successfully challenged a statutory demand for payment, securing a favourable Supreme Court ruling that removes a significant legal threat.

Corazon Mining reported a challenging cash flow quarter ending September 2025, with net outflows in operating and investing activities, but secured a $2 million capital raise to support ongoing exploration.

Auric Mining reports a positive operating cash flow for Q3 2025 and a new ore processing agreement, but faces a critical short-term funding gap.

Ark Mines Ltd reported a significant cash burn in the September quarter, prompting a $500,000 capital raise and plans to secure $4 million from a royalty sale to sustain operations.

Breakthrough Minerals Limited has voluntarily suspended trading on the ASX as it prepares to announce a significant mineral project acquisition and capital raising. The suspension is set to last until the announcement or the resumption of trading on 30 October 2025.

Stavely Minerals Limited reported a net cash outflow from operations of AUD 1.264 million for Q3 2025 but bolstered its cash reserves through financing activities, ending the quarter with AUD 1.722 million. The company signals a strategic reduction in exploration expenditure for the upcoming quarter to sustain operations.

HyTerra Ltd has successfully completed drilling and appraisal operations in Kansas, revealing elevated hydrogen and helium concentrations that reinforce the potential of its Nemaha Project. The company is advancing its US market presence with an OTCQB listing and strategic advisory appointments.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

Mont Royal Resources has completed a transformative merger with Commerce Resources, securing A$10 million to advance the Ashram Rare Earths Project, positioning itself as a key player in North America’s critical minerals sector.

L1 Group Limited has announced a $330 million equity raising to fund expansion initiatives, including new investment strategies and potential acquisitions, following its recent merger with Platinum Asset Management.